Ascendis Pharma A/S — All Filings
742 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
144
144/A
20-F
3
424B4
424B5
6-K
6-K/A
8-A12B
CERTNAS
CORRESP
CT ORDER
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
F-3ASR
F-3MEF
F-6
FWP
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SD
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | SC 13G/A | 0001104659-23-021469 | Feb 14, 2023 | — |
| SC 13G | ASCENDIS PHARMA A/S | 0000902664-23-001671 | Feb 14, 2023 | — |
| SC 13G/A | SC 13G/A | 0001193125-23-031590 | Feb 10, 2023 | — |
| SC 13G/A | — | 0000315066-23-001422 | Feb 9, 2023 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0000846087-23-000021 | Feb 6, 2023 | — |
| SC 13G | WESTFIELD CAPITAL MANAGEMENT COMPANY, L.P. | 0001085146-23-000558 | Feb 2, 2023 | — |
| 6-K | 6-K | 0001193125-23-006467 | Jan 11, 2023 | — |
| 6-K | 6-K | 0001193125-23-004171 | Jan 9, 2023 | — |
| 6-K | 6-K | 0001193125-23-004180 | Jan 9, 2023 | — |
| 6-K | 6-K | 0001193125-23-000736 | Jan 3, 2023 | — |
| 6-K | 6-K | 0001193125-22-304784 | Dec 14, 2022 | — |
| 6-K | 6-K | 0001193125-22-298027 | Dec 5, 2022 | — |
| 6-K | 6-K | 0001193125-22-283648 | Nov 14, 2022 | — |
| 6-K | 6-K | 0001193125-22-283750 | Nov 14, 2022 | — |
| 6-K | 6-K | 0001193125-22-283766 | Nov 14, 2022 | — |
| 6-K | 6-K | 0001193125-22-281195 | Nov 9, 2022 | — |
| 6-K | 6-K | 0000950170-22-021277 | Nov 2, 2022 | Sep 30, 2022 |
| 6-K | 6-K | 0001193125-22-275815 | Nov 2, 2022 | — |
| 6-K | 6-K | 0001193125-22-273181 | Oct 31, 2022 | — |
| 6-K | 6-K | 0001193125-22-261288 | Oct 12, 2022 | — |
| 6-K | 6-K | 0001193125-22-256242 | Oct 3, 2022 | — |
| 6-K | 6-K | 0001193125-22-255474 | Sep 30, 2022 | — |
| 6-K | 6-K | 0001193125-22-244724 | Sep 14, 2022 | — |
| 6-K | 6-K | 0001193125-22-242863 | Sep 12, 2022 | — |
| 6-K | 6-K | 0001193125-22-235191 | Aug 31, 2022 | — |
| 6-K | 6-K | 0001193125-22-219906 | Aug 12, 2022 | — |
| 6-K | FORM 6-K | 0001193125-22-217358 | Aug 10, 2022 | Jun 30, 2022 |
| 6-K | 6-K | 0001193125-22-217378 | Aug 10, 2022 | — |
| 6-K | 6-K | 0001193125-22-217350 | Aug 10, 2022 | — |
| 6-K | 6-K | 0001193125-22-192984 | Jul 13, 2022 | — |
| 6-K | 6-K | 0001193125-22-186150 | Jun 30, 2022 | — |
| 6-K | 6-K | 0001193125-22-174745 | Jun 15, 2022 | — |
| 6-K | 6-K | 0001193125-22-166205 | Jun 2, 2022 | — |
| SD | SD | 0001193125-22-161076 | May 26, 2022 | — |
| 6-K | 6-K | 0001193125-22-156873 | May 23, 2022 | — |
| 6-K | 6-K | 0001193125-22-147481 | May 11, 2022 | — |
| 6-K | 6-K | 0001193125-22-147494 | May 11, 2022 | Mar 31, 2022 |
| 6-K | 6-K | 0001193125-22-147518 | May 11, 2022 | — |
| 6-K | 6-K | 0001193125-22-135248 | May 2, 2022 | — |
| 6-K | 6-K | 0001193125-22-135235 | May 2, 2022 | — |
| 6-K | 6-K | 0001193125-22-104286 | Apr 13, 2022 | — |
| 6-K | 6-K | 0001193125-22-092159 | Apr 1, 2022 | Mar 31, 2022 |
| 6-K | 6-K | 0001193125-22-088237 | Mar 29, 2022 | — |
| 6-K | 6-K | 0001193125-22-073957 | Mar 14, 2022 | — |
| 6-K | 6-K | 0001193125-22-074087 | Mar 14, 2022 | — |
| 6-K | 6-K | 0001193125-22-070611 | Mar 9, 2022 | Feb 9, 2022 |
| 6-K | 6-K | 0001193125-22-062979 | Mar 2, 2022 | — |
| 20-F | FORM 20-F | 0001193125-22-062998 | Mar 2, 2022 | Dec 31, 2021 |
| SC 13G/A | ASCENDIS PHARMA A/S | 0001104659-22-022761 | Feb 14, 2022 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-22-022813 | Feb 14, 2022 | — |